Objective To examine the prognostic value of electroneuronography (ENoG) in predicting functional recovery in severe cases of acute facial palsy.
Methods Patients with severe degrees of facial palsy (initial House–Brackmann [HB] grades IV to VI) with available electrodiagnostic studies conducted 2–4 weeks after symptom onset were reviewed retrospectively. The patients were categorized into “good recovery” and “poor recovery” groups, with the former showing mild to no dysfunction (HB I to III) and the latter exhibiting moderate to severe dysfunction (HB IV to VI) on follow-up evaluation, 2 months after onset. ENoG amplitudes in four facial muscles (frontalis, nasalis, orbicularis oculi, and orbicularis oris), as well as age, sex, affected side, disease etiology, comorbidities, and laboratory findings, were compared between the two groups.
Results Thirty-seven patients were included. Twenty-nine of the patients showed “good recovery,” and eight showed “poor recovery” at 2 months after symptom onset. Univariate analysis yielded no significant difference in age, sex, affected side, disease etiology, comorbidities, and laboratory findings between the two groups. Preserved ENoG amplitudes (individual, average, and trimmed means) were significantly higher in the good recovery group than in the poor recovery group (p<0.005). Sex (p=0.038) and the ENoG of the nasalis muscle, acquired 2–4 weeks from symptom onset (p=0.004), showed significant differences in multivariate regression analysis.
Conclusion This study suggests that the female sex and lower ENoG of the nasalis muscle, acquired 2–4 weeks from symptom onset, have negative prognostic value for the 2-month functional outcome of severe facial palsy cases.
Citations
Citations to this article as recorded by
Importancia del electrodiagnóstico en la parálisis facial, una revisión narrativa de la literatura José Luis Pira Paredes, Julián David Ortiz, Daniel Francisco Osorio, Karina Góngora, Hedys Selene Ordoñez Mogollón Revista Colombiana de Medicina Física y Rehabilitación.2025; 35(1): e477. CrossRef
Prediction of early recovery in patients with acute peripheral facial paralysis using serial electroneuronography Yong Seok Jo, Seung Jae Lee, Hyun Jin Lee, Jeon Mi Lee, James J Cray Jr PLOS One.2025; 20(12): e0337613. CrossRef
Management of facial nerve trauma Rachel C. Greiner, Gavriel D. Kohlberg, G. Nina Lu Current Opinion in Otolaryngology & Head & Neck Surgery.2024; 32(4): 234. CrossRef
Predictive Value of the Neutrophil-to-Lymphocyte Ratio and C-Reactive Protein in Patients with Idiopathic Facial Nerve Palsy Longdong Xu, Tingting Guo, Xihua Sheng, Huaping Du, Ying Tang International Journal of General Medicine.2024; Volume 17: 2635. CrossRef
Study protocol for a randomized trial comparing two electroacupuncture waveforms for different severity groups of Bell palsy Zhiyuan Bian, Jiawei Wang, Fei Fang, Binyan Yu, Yan Shi, Yijia Wan, Mei Hong, Conghua Ji, Xiaomei Shao, Yi Liang, Jianqiao Fang, Jing Sun Frontiers in Neurology.2024;[Epub] CrossRef
Objective To systematically review the effect of intrathecal baclofen pump insertion in children with cerebral palsy (CP) with respect to scoliosis.
Methods A systematic literature search was conducted in PubMed, Embase, Cochrane Library, and Google Scholar databases up to June 2022. The inclusion criteria were as follows: (1) studies with a quantitative study design; (2) studies with a study group of children with CP; (3) studies comparing scoliosis in children with and without an intrathecal baclofen pump; and (4) studies with Cobb’s angle as a parameter.
Results Of the 183 studies found, four studies, all of which were retrospective comparative studies, met the aforementioned inclusion criteria. All studies were homogeneous (I2=0%, p=0.53) and intrathecal baclofen pump insertion accelerated the progression of scoliosis (standard mean difference=0.27; 95% confidence interval=0.07–0.48).
Conclusion Intrathecal baclofen pumps have been used to alleviate spasticity in children with CP, thus aiding their daily activities and movements. However, their advantages and disadvantages should be reviewed after sufficient time considering the pumps’ negative effect on the course of scoliosis.
Citations
Citations to this article as recorded by
Neurosurgery to restore function in cerebral palsy: current practice and emerging therapies Akshay Sankar, Awa Jobe, Bailey McDonald, Taylor J. Abel, Amit Sinha, Martin G. Piazza Frontiers in Rehabilitation Sciences.2026;[Epub] CrossRef
From childhood to adulthood: Long-term assessment of continuous intrathecal baclofen therapy in non-ambulant spastic cerebral palsy B.H.M. Martens, M. Iskander, D.L. Soudant, G.F. Vles, L.A. Bonouvrié, O.P.M. Teernstra, J.S.H. Vles, R.J. Vermeulen European Journal of Paediatric Neurology.2025; 56: 17. CrossRef
Lumbosacral Endoscopic Ventral–Dorsal Rhizotomy: A Novel Approach for Tone Reduction Lucinda T. Chiu, Benjamin E. Weiss, Nathan Pertsch, Olivia Rogers, Benjamin Katholi, Jeffrey S. Raskin Brain Sciences.2025; 15(10): 1030. CrossRef
Neuromuscular scoliosis: the why and the how of diagnosis and treatment Adam P Lloyd, Adrian Gardner, Athanasios I Tsirikos Orthopaedics and Trauma.2025; 39(6): 402. CrossRef
Delivery of Intrathecal Morphine Through Baclofen Pump for Perioperative Analgesia Austin W. Li, Christina K. Hardesty JAAOS: Global Research and Reviews.2025;[Epub] CrossRef
Pre-op considerations in neuromuscular scoliosis deformity surgery: proceedings of the half day course at the 58th annual meeting of the Scoliosis Research Society Michelle C. Welborn, Gregory Redding, Patrick Evers, Lindsey Nicol, David F. Bauer, Rajiv R. Iyer, Selina Poon, Steven Hwang Spine Deformity.2024; 12(4): 867. CrossRef
Cervicothoracic ventral-dorsal rhizotomy for treatment of brachial hypertonia in cerebral palsy Sunny Abdelmageed, Mahalia Dalmage, James M. Mossner, Robin Trierweiler, Tim Krater, Jeffrey S. Raskin Child's Nervous System.2024; 40(9): 2835. CrossRef
Intrathecal Baclofen Therapy: Pros and Cons Sung-Rae Cho Annals of Rehabilitation Medicine.2023; 47(1): 1. CrossRef
First
Prev
